We did not find evidence of significant effect modification by age, sex, BMI, current smoking, diabetes, hypertension, ALT, FBG, or triglycerides for the association of non-O blood groups with the risk of NAFLD (all Pinteraction>0.05) (Fig 2). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.